USD 24.57
(0.43%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 7.56 Billion EUR | 3.41% |
2022 | 7.36 Billion EUR | 11.34% |
2021 | 6.61 Billion EUR | -8.62% |
2020 | 7.23 Billion EUR | 0.12% |
2019 | 7.23 Billion EUR | 5.78% |
2018 | 6.83 Billion EUR | 2.72% |
2017 | 6.65 Billion EUR | -23.75% |
2016 | 8.72 Billion EUR | -1.55% |
2015 | 8.86 Billion EUR | 14.86% |
2014 | 7.71 Billion EUR | 0.63% |
2013 | 7.66 Billion EUR | -8.47% |
2012 | 8.37 Billion EUR | 10.82% |
2011 | 7.56 Billion EUR | 1.07% |
2010 | 7.48 Billion EUR | 0.21% |
2009 | 7.46 Billion EUR | -7.98% |
2008 | 8.11 Billion EUR | 10.69% |
2007 | 7.32 Billion EUR | 3.04% |
2006 | 7.11 Billion EUR | -11.4% |
2005 | 8.02 Billion EUR | -2.84% |
2004 | 8.26 Billion EUR | -3.57% |
2003 | 8.56 Billion EUR | -4.86% |
2002 | 9 Billion EUR | -4.68% |
2001 | 9.44 Billion EUR | 99.15% |
2000 | 4.74 Billion EUR | -8.35% |
1999 | 5.17 Billion EUR | -2.2% |
1998 | 5.29 Billion EUR | -14.7% |
1997 | 6.2 Billion EUR | 1.17% |
1996 | 6.13 Billion EUR | -20.92% |
1995 | 7.75 Billion EUR | 0.42% |
1994 | 7.72 Billion EUR | 0.84% |
1993 | 7.65 Billion EUR | -1.0% |
1992 | 7.73 Billion EUR | 16.27% |
1991 | 6.65 Billion EUR | -3.33% |
1990 | 6.88 Billion EUR | 0.31% |
1989 | 6.86 Billion EUR | 11.17% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q3 | 1.66 Billion EUR | 42.28% |
2024 Q2 | 1.17 Billion EUR | -55.53% |
2024 Q1 | 2.63 Billion EUR | 44.31% |
2023 Q2 | 1.74 Billion EUR | -25.61% |
2023 Q1 | 2.33 Billion EUR | 15.62% |
2023 Q4 | 1.82 Billion EUR | 6.9% |
2023 FY | 7.61 Billion EUR | 3.41% |
2023 Q3 | 1.71 Billion EUR | -1.72% |
2022 FY | 7.36 Billion EUR | 11.34% |
2022 Q4 | 2.02 Billion EUR | 4.87% |
2022 Q1 | 1.69 Billion EUR | -3.64% |
2022 Q3 | 1.92 Billion EUR | 12.09% |
2022 Q2 | 1.72 Billion EUR | 1.65% |
2021 Q1 | 1.53 Billion EUR | -25.72% |
2021 FY | 6.61 Billion EUR | -8.62% |
2021 Q4 | 1.75 Billion EUR | 8.79% |
2021 Q2 | 1.7 Billion EUR | 10.72% |
2021 Q3 | 1.61 Billion EUR | -5.22% |
2020 Q1 | 1.8 Billion EUR | -8.9% |
2020 FY | 7.23 Billion EUR | 0.12% |
2020 Q2 | 1.6 Billion EUR | -11.1% |
2020 Q3 | 1.76 Billion EUR | 9.99% |
2020 Q4 | 2.07 Billion EUR | 17.59% |
2019 Q3 | 1.83 Billion EUR | 3.21% |
2019 Q2 | 1.77 Billion EUR | 8.09% |
2019 Q1 | 1.64 Billion EUR | -14.43% |
2019 FY | 7.23 Billion EUR | 5.78% |
2019 Q4 | 1.97 Billion EUR | 7.91% |
2018 Q1 | 1.58 Billion EUR | -13.87% |
2018 Q2 | 1.7 Billion EUR | 7.83% |
2018 Q3 | 1.62 Billion EUR | -4.92% |
2018 Q4 | 1.92 Billion EUR | 18.23% |
2018 FY | 6.83 Billion EUR | 2.72% |
2017 Q4 | 1.83 Billion EUR | 13.8% |
2017 FY | 6.65 Billion EUR | -23.75% |
2017 Q3 | 1.61 Billion EUR | -2.83% |
2017 Q2 | 1.66 Billion EUR | -20.7% |
2017 Q1 | 2.09 Billion EUR | -11.85% |
2016 Q2 | 2.16 Billion EUR | 4.65% |
2016 Q3 | 2.12 Billion EUR | -1.8% |
2016 FY | 8.72 Billion EUR | -1.55% |
2016 Q1 | 2.06 Billion EUR | -22.43% |
2016 Q4 | 2.37 Billion EUR | 12.11% |
2015 Q1 | 1.97 Billion EUR | -16.48% |
2015 Q2 | 2.14 Billion EUR | 8.55% |
2015 Q3 | 2.07 Billion EUR | -3.12% |
2015 Q4 | 2.66 Billion EUR | 28.04% |
2015 FY | 8.86 Billion EUR | 14.86% |
2014 Q2 | 1.84 Billion EUR | 3.3% |
2014 Q3 | 1.91 Billion EUR | 3.68% |
2014 Q4 | 2.36 Billion EUR | 23.54% |
2014 FY | 7.71 Billion EUR | 0.63% |
2014 Q1 | 1.78 Billion EUR | -16.48% |
2013 Q1 | 1.79 Billion EUR | -35.3% |
2013 Q2 | 1.83 Billion EUR | 2.34% |
2013 Q3 | 1.89 Billion EUR | 2.99% |
2013 Q4 | 2.14 Billion EUR | 13.15% |
2013 FY | 7.66 Billion EUR | -8.47% |
2012 Q4 | 2.77 Billion EUR | 40.13% |
2012 FY | 8.37 Billion EUR | 10.82% |
2012 Q3 | 1.98 Billion EUR | 2.64% |
2012 Q2 | 1.93 Billion EUR | 3.99% |
2012 Q1 | 1.85 Billion EUR | -13.63% |
2011 Q4 | 2.14 Billion EUR | 19.85% |
2011 FY | 7.56 Billion EUR | 1.07% |
2011 Q3 | 1.79 Billion EUR | -0.99% |
2011 Q1 | 1.8 Billion EUR | -9.51% |
2011 Q2 | 1.81 Billion EUR | 0.22% |
2010 Q2 | 1.87 Billion EUR | 4.92% |
2010 Q4 | 1.99 Billion EUR | 9.85% |
2010 Q3 | 1.81 Billion EUR | -3.14% |
2010 FY | 7.48 Billion EUR | 0.21% |
2010 Q1 | 1.78 Billion EUR | -15.45% |
2009 Q1 | 1.82 Billion EUR | -23.96% |
2009 FY | 7.46 Billion EUR | -7.98% |
2009 Q4 | 2.11 Billion EUR | 21.68% |
2009 Q3 | 1.73 Billion EUR | -2.41% |
2009 Q2 | 1.78 Billion EUR | -2.52% |
2008 Q1 | 1.79 Billion EUR | -11.69% |
2008 Q2 | 1.84 Billion EUR | 2.66% |
2008 FY | 8.11 Billion EUR | 10.69% |
2008 Q3 | 1.9 Billion EUR | 3.16% |
2008 Q4 | 2.4 Billion EUR | 26.32% |
2007 FY | 7.32 Billion EUR | 3.04% |
2007 Q1 | 1.7 Billion EUR | -16.48% |
2007 Q4 | 2.03 Billion EUR | 13.56% |
2007 Q3 | 1.79 Billion EUR | -0.31% |
2007 Q2 | 1.79 Billion EUR | 5.64% |
2006 Q4 | 2.03 Billion EUR | 19.42% |
2006 Q2 | 2.13 Billion EUR | 5.99% |
2006 FY | 7.11 Billion EUR | -11.4% |
2006 Q1 | 2.01 Billion EUR | -1.95% |
2006 Q3 | 1.7 Billion EUR | -20.24% |
2005 Q2 | 2.11 Billion EUR | 11.36% |
2005 FY | 8.02 Billion EUR | -2.84% |
2005 Q4 | 2.05 Billion EUR | 5.63% |
2005 Q3 | 1.94 Billion EUR | -8.03% |
2005 Q1 | 1.9 Billion EUR | -34.94% |
2004 Q3 | 1.33 Billion EUR | -34.69% |
2004 Q4 | 2.92 Billion EUR | 119.02% |
2004 Q2 | 2.04 Billion EUR | 4.49% |
2004 FY | 8.26 Billion EUR | -3.57% |
2004 Q1 | 1.95 Billion EUR | -23.87% |
2003 Q2 | 1.98 Billion EUR | -0.25% |
2003 Q1 | 1.99 Billion EUR | -16.34% |
2003 Q4 | 2.56 Billion EUR | 27.73% |
2003 FY | 8.56 Billion EUR | -4.86% |
2003 Q3 | 2.01 Billion EUR | 1.16% |
2002 FY | 9 Billion EUR | -4.68% |
2002 Q4 | 2.38 Billion EUR | 17.41% |
2002 Q2 | 2.49 Billion EUR | 9.99% |
2002 Q3 | 2.02 Billion EUR | -18.74% |
2002 Q1 | 2.27 Billion EUR | -75.08% |
2001 Q4 | 9.11 Billion EUR | 5397.18% |
2001 FY | 9.44 Billion EUR | 99.15% |
2001 Q3 | 165.75 Million EUR | 116.73% |
2001 Q1 | 79.9 Million EUR | 101.63% |
2001 Q2 | 76.47 Million EUR | -4.29% |
2000 Q4 | -4.9 Billion EUR | -6963.66% |
2000 Q1 | - EUR | -100.0% |
2000 Q2 | 55.63 Million EUR | 0.0% |
2000 Q3 | 71.42 Million EUR | 28.36% |
2000 FY | 4.74 Billion EUR | -8.35% |
1999 Q1 | - EUR | -100.0% |
1999 FY | 5.17 Billion EUR | -2.2% |
1999 Q3 | - EUR | 0.0% |
1999 Q4 | 4.3 Billion EUR | 0.0% |
1999 Q2 | - EUR | 0.0% |
1998 Q4 | 5.29 Billion EUR | 623814.23% |
1998 Q3 | 848.54 Thousand EUR | 193.17% |
1998 Q1 | -928.51 Thousand EUR | -100.01% |
1998 FY | 5.29 Billion EUR | -14.7% |
1998 Q2 | -910.75 Thousand EUR | 1.91% |
1997 Q2 | - EUR | 0.0% |
1997 Q3 | - EUR | 0.0% |
1997 Q4 | 6.2 Billion EUR | 0.0% |
1997 FY | 6.2 Billion EUR | 1.17% |
1997 Q1 | - EUR | 100.0% |
1996 FY | 6.13 Billion EUR | -20.92% |
1996 Q4 | -30.74 Billion EUR | 0.0% |
1996 Q2 | - EUR | 0.0% |
1996 Q1 | - EUR | 100.0% |
1996 Q3 | - EUR | 0.0% |
1995 Q4 | -29.57 Billion EUR | 0.0% |
1995 Q3 | - EUR | 0.0% |
1995 Q2 | - EUR | 0.0% |
1995 FY | 7.75 Billion EUR | 0.42% |
1995 Q1 | - EUR | 100.0% |
1994 Q1 | - EUR | 100.0% |
1994 FY | 7.72 Billion EUR | 0.84% |
1994 Q3 | - EUR | 0.0% |
1994 Q2 | - EUR | 0.0% |
1994 Q4 | -27 Billion EUR | 0.0% |
1993 Q1 | - EUR | 100.0% |
1993 Q3 | - EUR | 0.0% |
1993 FY | 7.65 Billion EUR | -1.0% |
1993 Q4 | -26.05 Billion EUR | 0.0% |
1993 Q2 | - EUR | 0.0% |
1992 Q3 | - EUR | 0.0% |
1992 Q2 | - EUR | 0.0% |
1992 FY | 7.73 Billion EUR | 16.27% |
1992 Q4 | -25.64 Billion EUR | 0.0% |
1992 Q1 | - EUR | 100.0% |
1991 Q3 | - EUR | 0.0% |
1991 Q1 | - EUR | 100.0% |
1991 Q4 | -23.66 Billion EUR | 0.0% |
1991 Q2 | - EUR | 0.0% |
1991 FY | 6.65 Billion EUR | -3.33% |
1990 Q3 | - EUR | 0.0% |
1990 FY | 6.88 Billion EUR | 0.31% |
1990 Q1 | - EUR | 100.0% |
1990 Q2 | - EUR | 0.0% |
1990 Q4 | -23.22 Billion EUR | 0.0% |
1989 FY | 6.86 Billion EUR | 11.17% |
1989 Q4 | -24.51 Billion EUR | 0.0% |
1989 Q1 | - EUR | 100.0% |
1989 Q2 | - EUR | 0.0% |
1989 Q3 | - EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Abbott Laboratories | 15.71 Billion USD | 51.865% |
Allurion Technologies Inc. | 120.57 Million USD | -6172.445% |
Artivion, Inc. | 223.43 Million USD | -3284.892% |
Avanos Medical, Inc. | 375.5 Million USD | -1914.115% |
Butterfly Network, Inc. | 162.46 Million USD | -4555.128% |
Butterfly Network, Inc. | 162.46 Million USD | -4555.128% |
Bio-Rad Laboratories, Inc. | 1.04 Billion USD | -621.97% |
Boston Scientific Corporation | 7.47 Billion USD | -1.137% |
CONMED Corporation | 564.24 Million USD | -1240.382% |
Edwards Lifesciences Corporation | 3.09 Billion USD | -144.686% |
Paragon 28, Inc. | 210.1 Million USD | -3499.714% |
Glaukos Corporation | 367.83 Million USD | -1956.079% |
Globus Medical, Inc. | 887.16 Million USD | -752.496% |
Inspire Medical Systems, Inc. | 568.49 Million USD | -1230.357% |
Integer Holdings Corporation | 250.95 Million USD | -2913.64% |
Medtronic plc | 16.12 Billion USD | 53.109% |
Myomo, Inc. | 21.41 Million USD | -35218.128% |
Nevro Corp. | 389.36 Million USD | -1842.378% |
Owlet, Inc. | 51.21 Million USD | -14666.005% |
Penumbra, Inc. | 590.87 Million USD | -1179.962% |
Vicarious Surgical Inc. | 80.66 Million USD | -9275.697% |
Smith & Nephew plc | 3.46 Billion USD | -118.142% |
Sonendo, Inc. | 68.46 Million USD | -10946.52% |
STERIS plc | 1.4 Billion USD | -440.075% |
Stryker Corporation | 9.2 Billion USD | 17.874% |
Vapotherm, Inc. | 66.02 Million USD | -11354.752% |
Zimmer Biomet Holdings, Inc. | 3.27 Billion USD | -130.861% |